FDA agrees to fast-track review of Amarin’s prescription strength fish oil pill for heart patients

By

FDA agrees to fast-track review of Amarin's prescription strength fish oil pill for heart patients

The FDA plans to review Vascep within six months instead of the usual 10, with a decision on approval expected sometime in late September.

Source: Business News –

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.